{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:36:48Z","timestamp":1762004208687},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.urology.2009.06.085","type":"journal-article","created":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T06:33:47Z","timestamp":1255070027000},"page":"1373-1377","source":"Crossref","is-referenced-by-count":16,"title":["Surgical Treatment of Renal Cell Carcinoma in the Immunocompromised Transplant Patient"],"prefix":"10.1016","volume":"75","author":[{"given":"Matthew K.","family":"Tollefson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy E.","family":"Krambeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley C.","family":"Leibovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Blute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George K.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2009.06.085_bib1","first-page":"S328","article-title":"Incidence and treatment of neoplasia after transplantation","volume":"12","author":"Penn","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.urology.2009.06.085_bib2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6601219","article-title":"Cancer risk following organ transplantation: a nationwide cohort study in Sweden","volume":"89","author":"Adami","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2009.06.085_bib3","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.urology.2009.06.085_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.240.7.639","article-title":"Malignant neoplasms following cardiac transplantation","volume":"240","author":"Krikorian","year":"1978","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.urology.2009.06.085_bib5","first-page":"1","article-title":"The OPTN\/UNOS Renal Transplant Registry","author":"Cecka","year":"2005","journal-title":"Clin Transpl"},{"key":"10.1016\/j.urology.2009.06.085_bib6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1600-6143.2008.02310.x","article-title":"Twenty-year survivors of heart transplantation at Stanford University","volume":"8","author":"Deuse","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.urology.2009.06.085_bib7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.TP.0000131663.87106.1A","article-title":"Health status ten years after pediatric liver transplantation\u2014looking beyond the graft","volume":"78","author":"Avitzur","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.urology.2009.06.085_bib8","first-page":"513","article-title":"Incidence of skin cancer in 5356 patients following organ transplantation","volume":"143","author":"Lindelof","year":"2000","journal-title":"Br J Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.urology.2009.06.085_bib9","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.1111\/j.1432-2277.2000.tb02068.x","article-title":"Cancer incidence in a kidney-transplanted population","volume":"13","author":"Kyllonen","year":"2000","journal-title":"Transpl Int"},{"key":"10.1016\/j.urology.2009.06.085_bib10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1399-0012.2008.00796.x","article-title":"Three-year follow-up of malignancies in tacrolimus-treated renal recipients\u2014an analysis of European multicentre studies","volume":"22","author":"Cowlrick","year":"2008","journal-title":"Clin Transpl"},{"key":"10.1016\/j.urology.2009.06.085_bib11","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1158\/1078-0432.CCR-08-0656","article-title":"Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival","volume":"14","author":"van Cruijsen","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2009.06.085_bib12","doi-asserted-by":"crossref","first-page":"17174","DOI":"10.1073\/pnas.0406351101","article-title":"Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target","volume":"101","author":"Thompson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urology.2009.06.085_bib13","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1158\/1078-0432.CCR-08-0536","article-title":"Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma","volume":"14","author":"Crispen","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2009.06.085_bib14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.transproceed.2007.03.092","article-title":"Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus","volume":"39","author":"Mohsin","year":"2007","journal-title":"Transplant Proc"},{"issue":"suppl 4","key":"10.1016\/j.urology.2009.06.085_bib15","first-page":"32","article-title":"European best practice guidelines for renal transplantation","volume":"17","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.urology.2009.06.085_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.juro.2006.09.057","article-title":"Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score","volume":"177","author":"Thompson","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.06.085_bib17","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0022-5347(05)64153-5","article-title":"An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score","volume":"168","author":"Frank","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.06.085_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2796.1998.00339.x","article-title":"Nephron-sparing surgery and renal transplantation in patients with renal cell carcinoma and von Hippel\u2013Lindau disease","volume":"243","author":"Goldfarb","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.urology.2009.06.085_bib19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0090-4295(94)80224-6","article-title":"Renal transplantation in patients with renal cell carcinoma and von Hippel\u2013Lindau disease","volume":"44","author":"Steinbach","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.urology.2009.06.085_bib20","first-page":"459","article-title":"Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants","volume":"137","author":"Otley","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.urology.2009.06.085_bib21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0168-8278(03)00358-1","article-title":"Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin","volume":"39","author":"Tang","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.urology.2009.06.085_bib22","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/01.mlg.0000210544.64659.35","article-title":"Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII)","volume":"116","author":"Khariwala","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.urology.2009.06.085_bib23","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1078-0432.CCR-05-2170","article-title":"Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ","volume":"12","author":"Namba","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2009.06.085_bib24","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1097\/01.tp.0000250767.67472.58","article-title":"Conversion to sirolimus in renal transplant recipients with skin cancer","volume":"82","author":"Tessmer","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.urology.2009.06.085_bib25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation","volume":"17","author":"Campistol","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.urology.2009.06.085_bib26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1600-6143.2007.02145.x","article-title":"Last resort for renal transplant recipients, \u201crestored kidneys\u201d from living donors\/patients","volume":"8","author":"Mannami","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.urology.2009.06.085_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1399-0012.2005.00455.x","article-title":"Accidental transplantation of a kidney with a cystic renal cell carcinoma following living donation: management and 1 yr follow-up","volume":"20","author":"Neipp","year":"2006","journal-title":"Clin Transpl"},{"key":"10.1016\/j.urology.2009.06.085_bib28","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/01.tp.0000268482.48076.22","article-title":"Donor kidneys with small renal cell cancer or low-grade lower ureteral cancer can be transplanted","volume":"83","author":"Mitsuhata","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.urology.2009.06.085_bib29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.transproceed.2004.12.118","article-title":"Donor kidneys with small renal cell cancers: can they be transplanted?","volume":"37","author":"Buell","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.urology.2009.06.085_bib30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.juro.2007.09.077","article-title":"Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy","volume":"179","author":"Thompson","year":"2008","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429509022225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429509022225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T23:56:29Z","timestamp":1544918189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429509022225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0090429509022225"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2009.06.085","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}